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Illness Perceptions in Patients With Fibromyalgia and Their
Relationship to Quality of Life and Catastrophizing
C. Paul van Wilgen,1 Miriam W. van Ittersum,2 Ad A. Kaptein,3 and Marten van Wijhe4
Objective. In the last decade, illness perceptions
have been identified as important in the treatment of
fibromyalgia (FM). The aim of the present study was to
examine illness perceptions and use of the revised
Illness Perception Questionnaire in patients with FM
(IPQ-R-FM) and their relationship to quality of life and
catastrophizing.
Methods. A domain with specific causal attribu-
tions related to FM was added to the IPQ-R-FM. The
psychometric properties of the IPQ-R-FM dimensions
and attribution scales were examined. The causal do-
main, in which patients describe the most important
perceived causes for their FM, was analyzed. To analyze
the relationship with quality of life and catastrophizing,
the Fibromyalgia Impact Questionnaire and the Pain
Catastrophizing Scale were used.
Results. Fifty-one outpatients completed the
questionnaires on 2 occasions, 3 weeks apart. FM was
considered to be chronic and to have serious conse-
quences; patients perceived little personal control and
did not expect medical treatment to be effective. The
psychometric properties of the IPQ-R-FM were found to
be adequate. Patients most frequently attributed the
causes of FM to an external somatic source (58%).
Quality of life was related to experiencing more conse-
quences attributable to FM. Catastrophizing was re-
lated to a limited understanding of the symptoms of FM,
the more cyclical nature of FM, and an emotional
representation.
Conclusion. The IPQ-R-FM is a useful tool to
assess illness perceptions in patients with FM. Illness
perceptions are related to quality of life and catastroph-
izing; therefore, it seems important to assess and inte-
grate illness perceptions into the management of pa-
tients with FM.
The diagnosis of fibromyalgia (FM) relies on
symptom criteria, including widespread pain character-
ized by multiple tender points. Other symptoms fre-
quently reported are fatigue, stiffness, depression, ab-
dominal pain, and disturbed sleep (1). FM is a chronic
pain syndrome, the pathogenesis of which is unknown
but seems to depend on multiple factors that differ
among individual patients. These factors may consist of
physical, psychological, behavioral, cognitive, and envi-
ronmental components. The recommended treatment,
therefore, is characterized by a multimodal approach,
including pharmacotherapy and self-management (2,3).
Self-management programs for patients with FM incor-
porate combinations of several treatment strategies such
as exercise (4), education (5), and stress management
(6). Education (7) and psychoeducational interventions
(8) have been described as effective in the treatment of
patients with FM. Education aims at changing the
inadequate cognitions of patients.
In the last decade, cognitions and illness percep-
tions have been identified as important in the ability to
control musculoskeletal conditions such as FM. In both
cross-sectional and prospective studies across different
musculoskeletal conditions, catastrophizing has been
shown to be related to the severity of pain, affective
distress, muscle and joint tenderness, pain-related dis-
ability, poor treatment outcomes, and potentially to
inflammatory disease (9–11). The Pain Catastrophizing
Scale (PCS) is used to identify catastrophizing in pa-
tients with pain (12).
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When patients are confronted with an illness or
with symptoms, as in FM, they create a model and
representation of this illness or symptoms (illness per-
ceptions) in order to make sense of or try to cope with
the illness and its symptoms. Each patient will have his
or her own ideas about the identity, treatment, timeline,
and consequences of the illness or symptoms. In this
process, attributions are made in order to understand
the cause of the symptoms (e.g., a psychological attribu-
tion such as stress or a physical attribution such as
rheumatism). Leventhal et al developed the self-
regulation model (as a theoretical framework for com-
bining illness perceptions with coping and outcome; i.e.,
quality of life) (13). In order to assess illness percep-
tions, Weinman et al developed the Illness Perception
Questionnaire (IPQ) (14). This IPQ was later modified
by Moss-Morris et al into the revised IPQ (IPQ-R) (15).
The IPQ-R measures perceptions and attributions of
patients. It has been tested in different patient groups
such as those with Huntington’s disease (16), mild head
injuries (17), coronary artery disease (18), or head and
neck cancer (19). Stuifbergen et al used the IPQ-R in
patients with FM (20). In a cross-sectional study, those
investigators examined the links between illness percep-
tions, mental health, and health behavior and deter-
mined that the emotional representations of patients
with FM explained 41% of the variance of mental health
and 17% of health-related behavior.
Although illness perceptions have been shown to
be important, the integration of illness perceptions into
the clinical assessment and management of patients with
FM needs further elaboration and research. The psycho-
metric properties of the IPQ-R should be tested further,
and research should focus on the specific illness percep-
tions of patients with FM. The Fibromyalgia Impact
Questionnaire (FIQ) can be used to investigate the link
between the illness perceptions of patients with FM and
quality of life. It was demonstrated to be an efficient
questionnaire to evaluate the impact of FM on quality of
life (21).
The aims of the present study were to investigate
the illness perceptions of patients with FM, to analyze
the psychometric properties (interclass correlation, test–
retest reliability, and interrelationships), and to examine
the links between illness perceptions, quality of life
(using the FIQ), and catastrophizing (using the PCS).
PATIENTS AND METHODS
Patients were recruited from the Dutch FM patient
association (Fibromyalgie Eendrachtig Sterk [FES]) by means
of an announcement on the FES Web site. If a patient
expressed willingness to participate, he or she was asked,
through the Web site, to send an e-mail or letter to the
investigators. The patients then received additional informa-
tion concerning the study and a set of questionnaires (T1).
Three weeks after the patients filled out the questionnaires,
they received a second set of the same questionnaires (T2). All
patients were required to have FM according to the criteria
described by Wolfe et al (1), as diagnosed by a rheumatologist
or general practitioner, and to be experiencing pain, stiffness,
and fatigue at the moment of the study. Due to the test–retest
arrangement, patients were asked not to receive any new
treatment during the study period that could interfere with
their cognitions or attributions regarding FM.
The following sociodemographic and clinical data were
collected in the questionnaire: age, sex, number of painful
body sites (minimum  0, maximum  28), duration of pain,
time since the diagnosis of FM, pain intensity (numerical
rating scale [NRS], possible range 1–10), and medication use.
The IPQ-R was used to measure illness perceptions, and its
psychometric properties are accurate (14). The IPQ-R can be
used in different patient groups by adapting the questionnaire
to that specific patient group. In our study, the original IPQ-R
was translated into Dutch, and the terminology “my illness”
was changed into “my fibromyalgia”; the adapted question-
naire was labeled “IPQ-R-FM (Dutch language version).”
In the dimension of illness termed “identity,” patients
were asked if they experienced a specific symptom (based on a
total of 14 possible symptoms) and whether they believed the
symptom was related to their FM. In the next section, patients
were asked to indicate their level of agreement (on a 5-point
scale, where 1 strongly disagree and 5 strongly agree) with
statements concerning an acute/chronic timeline (5 items
about the chronicity of FM), a cyclical timeline (4 items about
the cyclical nature of FM), the consequences of FM (6 items
about the negative consequences of FM), personal control (6
items representing positive beliefs about personal controllabil-
ity), treatment control (5 items representing positive beliefs
about the treatment ability), illness coherence (5 items about
the personal understanding of FM), and emotional represen-
tation (6 items about emotions caused by FM). The causal
domain is presented as a separate section; it consists of 18
attribution items that can be divided into the following 4
subdimensions: psychological attributions such as personality,
stress, or worry (6 items), risk factors such as heredity and
smoking (7 items), immunity factors such as germs or viruses (3
items), and accident or chance (2 items). The causal domain of
the IPQ-R can be used for any disease.
Because patients with FM have specific beliefs regard-
ing the cause of their symptoms, an FM-specific dimension was
added to the IPQ-R-FM that included 8 FM-specific causes,
namely, rheumatism, muscular disease, a psychological trauma
in the past, hormonal deregulation, decreased vascularization,
overused tendomuscular junctions, sleeping problems, and
thyroid gland disease. These causes were based on the clinical
experience of the authors with patients with FM. For scoring
the IPQ-R-FM, we referred to the approach described by
Moss-Morris et al (15). The FM-specific causes are summed
(minimum 8, maximum 40). At the end of the IPQ-R-FM,
patients are asked to mention in their own words a maximum
of 3 causes for their FM. To analyze these causes, an attribu-
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tion model was adopted that contains the categories of psy-
chological or somatic cause and internal or external attribu-
tion. The model resulted in the following 5 options:
psychological cause/internal attribution, psychological cause/
external attribution, somatic cause/internal attribution, so-
matic cause/external attribution, and cause not classifiable.
To analyze the link between illness perception and
quality of life and catastrophizing, the FIQ and the PCS were
used. The FIQ is a self-administrated questionnaire with 10
items that include 4 subscales: physical impairment (11 sub-
items), number of days feeling good (range 0–7), number of
days unable to work (range 0–7), and 6 symptoms (pain,
fatigue, morning tiredness, stiffness, anxiety, and depression)
(score range 1–10) (22). The questionnaire has credible con-
struct validity, reliable test–retest characteristics, and good
sensitivity for therapeutic changes (23). The FIQ is frequently
used in studies of FM and is the most adequate method to
analyze quality of life in patients with FM (21). In this study,
the symptoms (pain, fatigue, morning tiredness, stiffness, anx-
iety, and depression) and the total score for the FIQ are used
to analyze the link between symptoms and quality of life with
the IPQ dimensions and attribution scales.
The PCS is a 13-item questionnaire in which patients
are asked to reflect on past painful experiences and indicate
the degree to which they experienced thoughts or feelings
during pain, on a 5-point scale. For this study, the total score
for the PCS was used. The psychometric properties of the PCS
are adequate (12,24).
All data were entered using SPSS version 14.0 (SPSS,
Chicago, IL). Descriptive statistics were used to describe the
sociodemographic data and history of pain. The internal
consistency (Cronbach’s alpha) for each dimension and attri-
bution was analyzed. Test–retest reliability over a 3-week
interval was calculated using Pearson’s correlations between
the 2 time points. Pearson’s correlation coefficients were
computed to investigate the interrelationships of the dimen-
sions of the IPQ-R-FM and the attributions. The causes
described by the patients were classified separately by 2
investigators. In case of discrepancies, the differences were
discussed until agreement was reached. To analyze the link
between the IPQ dimensions and quality of life and cata-
strophizing, Pearson’s correlations between the dimension and
attribution scales of the IPQ with the symptoms and total score
of the FIQ and the PCS were calculated.
RESULTS
Of the 58 patients included in the study, 51 were
analyzed. Six patients withdrew from the study, either
because they did not return the questionnaires (n  2)
or because they returned the questionnaires too late
(n  3). One patient received a new treatment during
the study period and was therefore excluded. The ma-
jority of the patients (92%) were female, which is
consistent with population characteristics of patients
with FM. Patients experienced pain for 10 years, and
the mean duration of time before receiving a diagnosis
of FM was 5 years. Patients experienced severe pain, as
evidenced by their mean  SD NRS score of 7.1  1.8.
Most patients took analgesics for their FM, and, al-
though this is not recommended, nonsteroidal antiin-
flammatory drugs and acetaminophen were taken on a
large scale (Table 1).
Patients experienced a mean  SD of 7.7  2.2
symptoms at T1 and 7.4  2.0 symptoms at T2. Of the
symptoms experienced, 5.5  2.4 at T1 and 5.6  2.2 at
T2 were perceived to be related to FM. Pain, fatigue,
and loss of strength were the most common symptoms
experienced by the patients, and these symptoms were
perceived as related to the FM (Table 2).
The dimensions of the IPQ-R-FM are shown in
Table 3. Patients perceived FM to be chronic with
serious consequences and perceived little personal con-
trol and little treatment control. The internal consistency
of the IPQ-R-FM is adequate (  0.70) for 5 dimen-
sions and attributions. No relationship between the 2
Table 1. Demographic data, marital status, education, socioeconomic
status, clinical characteristics, and use of pain medication in the 51
patients with FM*
Age, mean  SD years 44 10






Elementary/middle school 8 (16)





Disability pension/sick leave 12 (24)
Student 2 (4)
Stiffness, mean  SD NRS score (scale 1–10) 7.3  2.2
Fatigue, mean  SD NRS score (scale 1–10) 7.9  1.6
Pain intensity, mean  SD NRS score (scale 1–10) 7.1  1.8
Duration of pain/time since diagnosis of FM, mean years 10.1/5.2
No. of pain sites, mean  SD (possible range 0–28) 14.8  5.9
Pain medication
NSAIDs, including acetaminophen 37 (73)
NSAIDs plus benzodiazepines 1 (2)
Benzodiazepines or TCAs 1 (2)
Opioids plus benzodiazepines and/or TCAs 7 (14)
Opioids plus NSAIDs 3 (6)
No medication 2 (4)
Pain medication frequency
3 times daily 16 (31)
1–2 times daily 9 (18)
2–6 times weekly 15 (30)
1 time weekly 11 (22)
* Except where indicated otherwise, values are the number (%) of
patients. FM  fibromyalgia; NRS  numerical rating scale;
NSAIDs  nonsteroidal antiinflammatory drugs; TCAs  tricyclic
antidepressants.
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items for chance attribution was observed. Test–retest
reliability was analyzed over a period of 3 weeks. Pear-
son’s correlations between the dimensions at T1 and T2
showed overall good stability, despite some low correla-
tions for identity (0.24), personal control (0.57), and
illness coherence (0.55).
Several significant correlations among the scores
for the IPQ-R dimensions and attributions were ob-
served (Table 4). Treatment control and personal con-
trol were strongly correlated. Low illness coherence
means little personal understanding of the symptoms
and causes of FM; this limited personal understanding is
strongly related to an emotional representation. Patients
with more psychological attributions for their FM, such
as stress or “my emotional state,” had more risk factor
attributions such as eating habits or heredity (Table 4).
The FM-specific attributions were significantly related
to the psychological attributions and risk factor attribu-
tions. The attributions most frequently reported for the
cause of FM were overused tendomuscular junctions
(3.6 and 3.7 at T1 and T2, respectively), rheumatism (3.5
and 3.5, respectively), sleeping disturbances (3.2 and 3.0,
respectively), stress or worry (3.1 and 3.1, respectively),
chance or bad luck (3.1 and 3.1, respectively), and
altered immunity (3.1 and 2.9, respectively). These 6
causes were reported most often both at T1 and T2.
The last question on the IPQ-R-FM provided
patients with the opportunity to list a maximum of 3
causes for their FM. Patients reported a mean of 2.6
causes at T1 and a mean of 2.7 causes at T2. A somatic
cause was most frequently mentioned (in 64% of cases).
The causes most frequently reported were muscular
disease, vulnerability, and genetics. In 90% of cases,
these somatic causes had an external attribution such as
heredity or bad luck; in 10% of cases, these somatic
causes had an internal attribution such as working
overtime or not getting enough rest. Psychological
causes were mentioned in 31% of the cases, with an
external attribution in 35% and an internal attribution in
65% of these cases. Most of the psychological causes
reported were stress, perfectionism, or a psychologically




my diagnosis of FM
I have experienced
these symptoms as
related to my FM
Pain 98/94 96/100
Fatigue 98/92 92/98
Loss of strength 92/85 85/93
Sleep difficulties 83/79 88/83
Stiff joints 79/87 85/89
Upset stomach 64/69 48/56
Headaches 62/58 47/57




Sore throat 19/10 30/20
Wheezing 13/8 29/0
Weight loss 2/2 100/100
* Values are the percent of 51 patients who responded “yes” on the
first/second revised Illness Perception Questionnaires. FM  fibromy-
algia.










Dimension (no. of items)
Identity (14) 5.5 2.4 0.24
Timeline, acute/chronic (6) 25.4  3.9 0.80 0.69†
Consequences (6) 19.3 4.1 0.64 0.75†
Personal control (6) 19.5 4.2 0.83 0.57†
Treatment control (5) 15.7 3.2 0.67 0.72†
Illness coherence (5) 15.9 3.4 0.51 0.55†
Cyclical timeline (4) 15.0  3.3 0.77 0.77†
Emotional representation (6) 16.2 5.1 0.86 0.72†
Attribution (no. of items)
Psychological attribution (6) 14.7 5.8 0.90 0.85†
Risk factor attribution (7) 15.1 3.6 0.48 0.69†
Immune attribution (3) 7.4 2.0 0.47 0.73†
Chance attribution (2) 5.5 1.7 0.00 0.62†
FM-specific attribution (8) 23.5 4.7 0.61 0.65†
* IPQ-R-FM  revised Illness Perception Questionnaire in patients with fibromyalgia (FM).
† P  0.01.
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traumatic event. Of the reported causes, 5% were not
classifiable. Answers such as “I don’t know what the cause
is” or “the cause is my FM” illustrate this.
The quality of life of patients with FM was
related to the number of consequences that patients
experience (Table 5). Catastrophizing was significantly
related to a low understanding of the symptoms of FM
and positively related to the more cyclical nature of FM
and an emotional representation. Fatigue was related to
experiencing more consequences of FM and a low
degree of personal control. Anxiety was related to
experiencing more consequences of FM, to an emotional
representation of FM, and to more psychological attri-
butions and more FM-specific attributions. Feeling de-
pressed was related to a low score for illness coherence,
reflecting that these patients do not understand the
Table 4. Pearson’s correlations between IPQ-R-FM dimensions and attributions about the cause of FM in 51 patients*
Dimension or attribution
1 2 3 4 5 6 7 8 9 10 11 12
Dimension (no. of items)
1. Identity (14)
2. Timeline, acute/chronic (6) 0.16
3. Consequences (6) 0.20 0.12
4. Personal control (6) 0.14 0.31† 0.21
5. Treatment control (5) 0.10 0.34† 0.22 0.73‡
6. Illness coherence (5) 0.29† 0.07 0.18 0.20 0.18
7. Cyclical timeline (4) 0.36† 0.17 0.08 0.13 0.16 0.29†
8. Emotional representation (6) 0.05 0.06 0.28† 0.25 0.25 0.49‡ 0.13
Attribution (no. of items)
9. Psychological attribution (6) 0.11 0.02 0.24 0.11 0.16 0.15 0.10 0.27
10. Risk factor attribution (7) 0.24 0.09 0.09 0.23 0.15 0.13 0.01 0.11 0.58‡
11. Immune attribution (3) 0.08 0.17 0.07 0.01 0.21 0.16 0.07 0.03 0.09 0.26
12. Chance attribution (2) 0.14 0.05 0.19 0.09 0.06 0.24 0.06 0.07 0.01 0.22 0.17
13. FM-specific attributions (8) 0.30† 0.13 0.35† 0.09 0.04 0.26 0.10 0.07 0.42‡ 0.54‡ 0.21 0.28†
* Values are Pearson’s correlation coefficients. Results are based on the revised Illness Perception Questionnaire in patients with fibromyalgia
(IPQ-R-FM) that was administered.
† P  0.05.
‡ P  0.01.







tiredness Stiffness Anxiety Depressed
Dimension
1. Identity 0.10 0.23 0.35† 0.25 0.03 0.09 0.31† 0.14
2. Timeline, acute/chronic 0.23 0.05 0.34† 0.30† 0.18 0.10 0.19 0.27
3. Consequences 0.28 0.37‡ 0.18 0.25 0.45‡ 0.28 0.62‡ 0.16
4. Personal control 0.02 0.37‡ 0.13 0.18 0.03 0.11 0.22 0.22
5. Treatment control 0.01 0.18 0.15 0.15 0.01 0.06 0.10 0.20
6. Illness coherence 0.20 0.20 0.08 0.01 0.32† 0.36‡ 0.06 0.42‡
7. Cyclical timeline 0.23 0.03 0.07 0.03 0.17 0.01 0.03 0.41‡
8. Emotional representation 0.09 0.16 0.15 0.03 0.48‡ 0.45‡ 0.30† 0.64‡
Attribution
9. Psychological attribution 0.09 0.17 0.04 0.08 0.58‡ 0.59‡ 0.28† 0.20
10. Risk factor attribution 0.07 0.05 0.08 0.03 0.27 0.20 0.09 0.05
11. Immune attribution 0.19 0.13 0.20 0.09 0.08 0.01 0.02 0.20
12. Chance attribution 0.17 0.32† 0.02 0.04 0.01 0.08 0.10 0.01
13. FM-specific attributions 0.10 0.19 0.25 0.15 0.41‡ 0.23 0.36† 0.15
* Values are Pearson’s correlation coefficients. IPQ-R-FM  Revised Illness Perception Questionnaire in patients with fibromyalgia (FM); FIQ 
Fibromyalgia Impact Questionnaire; PCS  Pain Catastrophizing Scale.
† P  0.05.
‡ P  0.01.
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symptoms of their FM. Feeling depressed was also
related to an emotional representation and more psy-
chological attributions.
DISCUSSION
The purpose of this study was to explore the
illness perceptions of patients with FM and to analyze
the internal consistency, test–retest reliability, and inter-
correlations of the IPQ-R-FM dimensions and attribu-
tions. Furthermore, the illness perceptions of patients
were analyzed, and the relationship to quality of life and
catastrophizing was examined.
Illness perceptions are related to the symptoms
that patients experience. In this study, patients with FM
experienced a mean of 7.6 symptoms. The symptoms
that patients experienced most commonly were pain,
fatigue, loss of strength, sleep difficulties, and stiff joints.
Except for loss of strength, these symptoms were related
to the diagnosis of FM. The same most common symp-
toms were described by Stuifbergen et al in a group of
US patients with FM (20). Despite the fact that in their
study 19 symptoms could be identified, the mean num-
ber of symptoms experienced was much higher than in
our study (namely, 14). In both study groups, the dura-
tion of FM was 10 years; the main difference between
the study populations was the fact that the US group was
recruited from a waiting list before an intervention. We
interpret this finding by stating that either patients with
FM who seek medical care report more symptoms or
that patients who experience more symptoms are seek-
ing medical care, even after more than 10 years. Patients
with FM experience more symptoms than patients with
chronic pain (6.2 symptoms), those with acute pain (2.8
symptoms) (15), and those with rheumatoid arthritis
(RA) (7.3 symptoms) but fewer symptoms than patients
with chronic fatigue syndrome (9.3 symptoms) (25). The
many symptoms experienced by patients underline the
fact that FM is a serious health problem.
The outcome indicates that patients experienced
their FM to be chronic and to have serious conse-
quences. Patients experience little personal control and
have low expectations of effective treatment. Compared
with patients with RA (25), patients with FM attribute
more symptoms to their FM, expect a more chronic
course, experience fewer consequences of their FM, and
experience FM as a less coherent condition. Compared
with patients with chronic fatigue syndrome (25), pa-
tients with FM attribute fewer symptoms to their FM
and consider the chronicity of the condition to be worse
but its negative consequences to be fewer. Patients with
FM report having less personal control and lower expec-
tations of treatment than patients with chronic fatigue
syndrome. US patients with FM experience more con-
sequences due to their FM, are more positive about
treatment opportunities, and have a more emotional
representation (20).
Interclass correlations for dimensions and attri-
butions were moderate to good, except for the item
chance attribution. This is a dimension with 2 questions
referring to FM caused by chance or accident. A rela-
tionship between these 2 questions was absent, just as
described in the study by Moss-Morris et al, who re-
ported an internal consistency of 0.23 for this chance
attribution. The use of this dimension should be recon-
sidered. The test–retest reliability of the IPQ-R-FM in
patients with FM is accurate (except for the identity
scale [0.24]).
This low correlation on the identity scale reflects
the change in symptoms experienced over time. The
main symptoms, such as pain, fatigue, and loss of
strength, were experienced by almost all patients at both
time points (T1 and T2). The symptoms that changed
over time were those experienced less often, such as stiff
joints, sleep difficulties, upset stomach, headaches, and
sore eyes.
Several significant interrelationships between di-
mensions were observed. Treatment control was strongly
associated with personal control; this strong correlation
(0.73) was also reported by Stuifbergen et al (20).
During development of the IPQ-R, support was found
for classifying personal control and treatment control as
separate components, particularly the link between ill-
ness representation and treatment adherence. As dis-
cussed by Moss-Morris et al, this distinction may differ
between illnesses. In patients with FM, the personal
control and treatment control dimensions are strongly
related. Probably, both personal control and treatment
control in FM aim at self-efficacy to manage the symp-
toms, because no specific medical treatment is available.
Moss-Morris et al stated that researchers should
modify the causal and identity scales in order to suit
particular illnesses or adapt to cultural settings. We
therefore added FM-specific attributions to the ques-
tionnaire. The FM-specific attributions were most fre-
quently mentioned by patients (e.g., overused tendo-
muscular junctions and rheumatism); these attributions
are important and should be elicited by clinicians when
interviewing patients with FM. The FM-specific domain
that we added contains somatic and psychological attri-
butions. Future studies should focus on illness-specific
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attributions and explore which ones can be added to the
IPQ-R-FM.
In the last question of the IPQ-R-FM, patients
are asked to describe, at most, 3 important causes for
their FM. With this open-ended format, a wealth of
personal information is obtained from the patients.
Although this specific question is rarely described in
studies of the IPQ-R, we believe this is relevant infor-
mation. We chose a model to analyze this question,
which could be relevant for clinicians when trying to
understand the illness perceptions of patients with FM.
The psychological versus somatic dichotomy is relevant
for the interaction between patients and physicians.
Internal versus external attribution is relevant for treat-
ment motivation, although the relationship between
illness perceptions and motivation is not yet clear (26).
In the medical literature, FM is often described
as a medically unexplained syndrome or a functional
somatic syndrome (27). The diagnosis is determined by
exclusion of diseases such as RA, and the diagnosis is
based on specific criteria defined by Wolfe et al (1). FM
is “not popular” among physicians and medical students
(28), and the physician–patient interaction is often con-
sidered to be difficult (29,30). The majority of the
patients in this study reported a somatic, external source
(e.g., muscular disease, vulnerability, overused tendo-
muscular junctions, or rheumatism) as the most impor-
tant cause for their FM. This finding seems to contrast
with what is known from the medical literature about the
cause of FM. This contrast in attributions for the cause
of FM could be part of the difficult physician–patient
interaction. Physicians should anticipate that many pa-
tients will attribute their FM to a somatic cause and are
searching for a treatment that fits this attribution. The
IPQ-R-FM can be used in this process, or patients can
be asked for their specific illness perceptions. Specific
education or reattribution programs that focus on these
inadequate cognitions have shown positive results on
pain intensity, catastrophizing, and physical outcome in
patients with low back pain (31) and in patients with FM
(32). The benefits of exercise programs are enhanced
when such programs are combined with self-management
education (33).
Measuring the quality of a patient’s life gives
insight into the impact of FM on the patient’s psycho-
logical, physical, and social functioning. Patients with
FM have a significantly worse quality of life compared
with healthy individuals and patients with RA (34).
Patients experiencing more consequences of their FM
report a worse quality of life. These patients see their
FM as a serious condition with major consequences for
their daily life, with many negative financial and social
ramifications. Experiencing more consequences is also
related to more fatigue. This underlines the fact that it is
important for treatment programs to aim at improving
these consequences.
Catastrophizing was found to be negatively re-
lated to illness coherence and positively related to a
cyclical timeline and an emotional representation. An
inability to understand the experienced symptoms prob-
ably increases the tendency to catastrophize. Experienc-
ing FM as cyclical and feeling that symptoms are chang-
ing over time but are unpredictable also relate to
catastrophizing as well as perceiving many emotional
consequences and perceiving FM as a serious disease.
Informing patients about their symptoms and trying to
reassure them seems essential to break this vicious circle
of catastrophizing. This education, however, should be
part of a wider pain management approach.
The results of the present study support the
IPQ-R-FM as a useful tool to assess illness perceptions
in patients with FM. The outcomes on the IPQ-R
dimensions reflect the expected pattern of patients with
a long duration of FM. The interclass correlations, the
test–retest reliability, and the interrelationships are suf-
ficient. Modifications can be made by adding FM-
specific causes and removing the chance attribution.
Clinicians should assess illness perceptions in patients
with FM in order to better understand perceived disabil-
ity and to anticipate treatment strategies. Pretreatment
illness perceptions and the changing of these beliefs are
associated with better outcome and are therefore impor-
tant in selecting patients for treatment programs (35).
Dijkstra et al reported that patients with FM who
describe fewer psychosocial causes and perceive fewer
psychosocial influences in relation to their FM are less
willing to adopt a self-management approach to coping
with FM (36).
A weakness of this study was that patients were
invited by means of an announcement on the Web site of
a patient organization. From studies on patients with
breast cancer, it is known that patients who participate in
a support group have different illness beliefs: they report
more active coping strategies and feel more control over
their cancer than patients who do not participate in such
groups (37,38). The manner in which this selection bias
influenced the illness perceptions of patients with FM
should be further investigated. The diagnosis of FM
according to the criteria described by Wolf et al (1) was
an inclusion criterion. These criteria are widely used by
rheumatologists and general practitioners in The Neth-
erlands. All patients experienced severe pain, stiffness,
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and fatigue at the time of the study, but the patients who
participated were not physically examined for the pres-
ence of the American College of Rheumatology 1990
criteria for the classification of FM (1). Comorbidities
were not assessed in the study. The presence of comor-
bidities might influence the illness perceptions of pa-
tients with FM.
Classifying the causes according to the model
(psychological versus somatic attribution, internal versus
external attribution) that we adopted was sometimes
difficult, for instance, in the case of sleeping problems
(somatic or psychological) or stress (internal or exter-
nal). Improved models could be used to better analyze
these qualitative data. Future studies should analyze this
model and test the relevance for clinicians. The sample
size of the study was small, but given the purposes of this
study, it is adequate.
Illness perceptions are relevant in patients with
FM. The results of the present study form a basis on
which to further investigate and implement illness per-
ceptions in clinical practice.
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